BRIEF-AIM Vaccine Logs H1 Capex RMB 102.5 MlnAug 27 (Reuters) - AIM Vaccine Co Ltd 6660.HK:
H1 CAPEX RMB 102.5 MILLION
H1 REVENUE RMB 514.7 MILLION
H1 GROSS MARGIN 66.3%
H1 GROSS PROFIT RMB 341.2 MILLION
HY LOSS ATTRIBUTABLE RMB131.1 MILLION
Further company coverage: 6660.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments